BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

  April 8, 2025

   · 

  9 min read
• Press Releases

  Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting

  April 8, 2025

   · 

  9 min read
• Press Releases

  Amneal to Report First Quarter 2025 Results on May 2, 2025

  April 8, 2025

   · 

  1 min read
• Press Releases

  USANA Schedules First Quarter 2025 Earnings Release and Conference Call

  April 8, 2025

   · 

  1 min read
• Press Releases

  ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor

  April 8, 2025

   · 

  5 min read
• Press Releases

  TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

  April 8, 2025

   · 

  14 min read
• Press Releases

  Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial

  April 8, 2025

   · 

  2 min read
• Press Releases

  CardioVia Announces FDA Clearance for ViaOne, Opening a New Frontier in Minimally Invasive Heart-Surface Treatments

  April 8, 2025

   · 

  2 min read
• Press Releases

  GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

  April 8, 2025

   · 

  2 min read
• Press Releases

  Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT

  April 8, 2025

   · 

  7 min read